-
FDA asks Ariad Pharmaceuticals to suspend sales, marketing of Iclusig amid side-effect concerns
SILVER SPRING, Md. — The Food and Drug Administration has asked Ariad Pharmaceuticals to suspend marketing and sales of a chemotherapy drug for leukemia due to the risk of life-threatening side effects, the agency said.
-
PTCB revises certification exam for pharmacy techs
WASHINGTON — Medication safety and pharmacy information systems get more attention in the latest version of an exam for pharmacy technicians.
The Pharmacy Technician Certification Board announced Friday updates to the Pharmacy Technician Certification Exam, based on the group's Job Analysis Study, which involves more than 25,000 pharmacy technicians from across the country and from different practice settings. The updated exam has nine knowledge groups known as domains, rather than three.